HOME >> BIOLOGY >> NEWS
Leaders in sickle cell research meet in Cincinnati

CINCINNATI The Cincinnati Comprehensive Sickle Cell Center at Cincinnati Children's Hospital Medical Center will host the 28th annual meeting of the National Sickle Cell Disease Program from April 10 to 13 at the Northern Kentucky Convention Center in Covington.

World leaders in sickle cell research will present new research findings at the meeting. Some 200 presentations on topics ranging from complications of having sickle cell disease (pain, sleep disorders, stroke, neurological functioning, pulmonary hypertension) to the challenges of treating sickle disease in Africa will be presented.

Also on April 10, Cincinnati Children's and the Sickle Cell Awareness Group of Greater Cincinnati will host a community and family forum, "Sickle Cell: Beyond the Basics," from 12:30 to 6 p.m. at the Cincinnati Marriott at RiverCenter in Covington. The public forum is for families with sickle cell disease and the sickle cell trait, advocates and others interested in learning more about the disease. (Attendees must register in advance by April 1 by calling 513-281-4450.)

Sickle cell disease affects approximately 72,000 Americans, most of who are of African, Mediterranean and Middle Eastern descent. The disease disproportionately affects African Americans one in every 400 as compared to one in every 1,000 to 1,400 Hispanics.

Researchers are making strides in improving treatments for people with sickle cell disease and in developing a cure for the disease, according to Clinton Joiner, M.D., Ph.D., director of the Cincinnati Comprehensive Sickle Cell Center at Cincinnati Children's.

"The meeting, held four of every five years since 1972, represents a major national and international forum for researchers in sickle cell disease. It has become an important venue for basic science investigators, clinicians, service providers and advocacy groups to interact and collaborate with one another," he said.

Sickle cell disease is a genetic
'"/>

Contact: Amy Reyes
amy.reyes@cchmc.org
513-636-9684
Cincinnati Children's Hospital Medical Center
21-Mar-2005


Page: 1 2

Related biology news :

1. Conservation Leadership Program announces 2007 awardees
2. Scientific American names UCSB professor, alumna to list of Top 50 in Technological Leadership
3. Public Leadership in Neurology Award honors Cuba Gooding, Jr., for multiple sclerosis awareness
4. Eighteen researchers selected as 2006 Aldo Leopold Leadership Fellows
5. Workshop: Canadas Leadership in International Innovation
6. Ossur congratulates Hugh Herr on Popular Mechanics 2005 Breakthrough Leadership Award
7. HO-1 in sickle cell disease: friend or foe?
8. Discovery promises simpler therapy for sickle cell disease
9. UNC scientists identify sticky protein in sickle cell red blood cells
10. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
11. Saudi Arabias KAUST names WHOI first research partner

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leaders sickle cell research meet Cincinnati

(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/10/2015)... Mass., Feb. 10, 2015  Alere Inc. (NYSE: ... its financial results for the quarter ended December ... Officer and President of Alere said, "We made ... Alere as the global leader in rapid diagnostics ... the Alere Health divestiture in early January enabled ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine” or ... a fraudulent press release disseminated this morning by PR ... Immunovaccine. This press release states that Immunovaccine has entered ... The press release did not originate from Immunovaccine and ... the press release. Please note that all official ...
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... 2015  23andMe, the leading personal genetics company, today ... Privacy Officer and Corporate Counsel. Black brings a strong ... well as health care regulations. As a member of ... for reviewing, updating and enhancing the company,s privacy and ... She joined the company January 5, 2015 and reports ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
Cached News: